Table IV.
IL-17 (ng·ml−1) | ||||||
---|---|---|---|---|---|---|
Group | Qty (n) | 1 day | 7 days | 14 days | 21 days | 28 days |
Model observation group | 53 | 18.92±3.51 | 43.85±11.93a | 53.27±10.33b | 72.05±11.38c | 86.46±10.28d |
Blank control group | 40 | 11.28±3.06 | 11.37±4.28 | 13.13±3.09 | 14.37±3.23 | 11.75±5.07 |
t value | 4.63 | 5.97 | 6.22 | 7.03 | 8.16 | |
P-value | 0.046 | 0.031 | 0.028 | 0.017 | 0.011 |
Comparisons of IL-17 levels at 1, 7, 14, 21 and 28 days after modeling in model observation group: in the comparison of IL-17 levels at 7 days and 1 day after modeling
t=5.36, P<0.05; in the comparison of IL-17 levels at 14 and 7 days after modeling
t=3.19, P<0.05; in the comparison of IL-17 levels at 21 and 14 days after modeling
t=4.26, P<0.05; in the comparison of IL-17 levels at 28 and 21 days after modeling
t=3.76, P<0.05.